In last trading session, Larimar Therapeutics Inc (NASDAQ:LRMR) saw 0.51 million shares changing hands with its beta currently measuring 0.95. Company’s recent per share price level of $3.19 trading at -$0.08 or -2.45% at ring of the bell on the day assigns it a market valuation of $203.55M. That closing price of LRMR’s stock is at a discount of -304.7% from its 52-week high price of $12.91 and is indicating a premium of 5.64% from its 52-week low price of $3.01.
For Larimar Therapeutics Inc (LRMR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.08. Splitting up the data highlights that, out of 2 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 2 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.32 in the current quarter.
Larimar Therapeutics Inc (NASDAQ:LRMR) trade information
Upright in the red during last session for losing -2.45%, in the last five days LRMR remained trading in the red while hitting it’s week-highest on Tuesday, 02/18/25 when the stock touched $3.19 price level, adding 9.38% to its value on the day. Larimar Therapeutics Inc’s shares saw a change of -17.57% in year-to-date performance and have moved -2.45% in past 5-day. Larimar Therapeutics Inc (NASDAQ:LRMR) showed a performance of -7.80% in past 30-days.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 78.73% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 22. It follows that stock’s current price would drop -338.87% in reaching the projected high whereas dropping to the targeted low would mean a loss of -338.87% for stock’s current value.
Larimar Therapeutics Inc (LRMR) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 48.33% during past 5 years.
Larimar Therapeutics Inc (NASDAQ:LRMR)’s Major holders
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) is the top institutional holder at LRMR for having 21.23 million shares of worth $153.93 million. And as of 2024-06-30, it was holding 33.278 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 6.05 million shares on 2024-06-30. The number of shares represents firm’s hold over 9.4752 of outstanding shares, having a total worth of $43.83 million.
On the other hand, Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Sep 30, 2024 , the former fund manager was holding 1.34 shares of worth $4.28 million or 2.10% of the total outstanding shares. The later fund manager was in possession of 1.19 shares on Nov 30, 2024 , making its stake of worth around $3.79 million in the company or a holder of 1.86% of company’s stock.
